| Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions (NCT02124239) | LEO Pharma | 2014-04-01 |
| Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) (NCT02200848) | Georgetown University | 2014-04-01 |
| Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1500 (NCT02107872) | Regeneron Pharmaceuticals | 2014-04-01 |
| Safety Trial Of CTX Cells In Patients With Lower Limb Ischaemia (NCT01916369) | ReNeuron Limited | 2014-04-01 |
| Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia (NCT02467257) | Al-Neelain University | 2014-04-01 |
| ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate (NCT02106507) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252 (NCT02120976) | Akros Pharma Inc. | 2014-04-01 |
| A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects (NCT02138773) | Astellas Pharma China, Inc. | 2014-04-01 |
| Icariin to Prevent Corticosteroid-related Memory Changes (NCT02112123) | University of Texas Southwestern Medical Center | 2014-04-01 |
| A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication (NCT02089581) | Mundipharma Research Limited | 2014-04-01 |
| Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant (NCT03301168) | Bellicum Pharmaceuticals | 2014-04-01 |
| Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients (NCT02129439) | Sterna Biologicals GmbH & Co. KG | 2014-04-01 |
| Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment (NCT02150733) | Daiichi Sankyo | 2014-04-01 |
| 1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML) (NCT02283190) | Ashkan Emadi | 2014-04-01 |
| A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers (NCT02133937) | Hoffmann-La Roche | 2014-04-01 |
| Pre-Exposure Prophylaxis (PrEP) Adherence Monitoring Using Dried Blood Spots (NCT02022657) | University of Colorado, Denver | 2014-04-01 |
| CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial. (NCT02132624) | Uppsala University | 2014-04-01 |
| Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects (NCT02675660) | Universitätsklinikum Hamburg-Eppendorf | 2014-04-01 |
| Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma (NCT02056756) | Stichting European Myeloma Network | 2014-04-01 |
| iDropper Usability in Glaucoma (NCT02031380) | Care Team Solutions | 2014-04-01 |
| PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers (NCT02121860) | Conatus Pharmaceuticals Inc. | 2014-04-01 |
| Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate) (NCT02530541) | Medline Industries | 2014-04-01 |
| Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects (NCT02071381) | Daewon Pharmaceutical Co., Ltd. | 2014-04-01 |
| A Crossover Study to Evaluate Relative Bioavailability of Two JNJ-54781532 Tablet Formulations in Healthy Adult Participants (NCT02117505) | Janssen Research & Development, LLC | 2014-04-01 |
| Bacterially-synthesized Folate Absorption Across the Large Intestine (NCT02299778) | The Hospital for Sick Children | 2014-04-01 |
| Photoallergy Potential of Dapsone Gel in Healthy Volunteers (NCT02117739) | Almirall, S.A. | 2014-04-01 |
| ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors (NCT02100007) | MEI Pharma, Inc. | 2014-04-01 |
| Choline Dehydrogenase and Sperm Function: Effects of Betaine (NCT02122211) | University of North Carolina, Chapel Hill | 2014-04-01 |
| A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese Participants (NCT02071355) | Janssen Research & Development, LLC | 2014-04-01 |
| A Study to Evaluate the Safety of the Respiratory Syncytial Virus Vaccine MEDI7510 in Older Adults (NCT02115815) | MedImmune LLC | 2014-04-01 |
| To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet (NCT02108639) | Bristol-Myers Squibb | 2014-04-01 |
| A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State. (NCT02133820) | Mundipharma Research Limited | 2014-04-01 |
| Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy Women (NCT02112903) | H. Lundbeck A/S | 2014-04-01 |
| Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy Volunteers (NCT02374437) | Galmed Pharmaceuticals Ltd | 2014-04-01 |
| Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects. (NCT02084056) | Boehringer Ingelheim | 2014-04-01 |
| Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome (NCT02034071) | Essentialis, Inc. | 2014-04-01 |
| Neuromyelitis Optica (NMO) & Cetirizine (NCT02865018) | Icahn School of Medicine at Mount Sinai | 2014-04-01 |
| Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck) (NCT02479854) | Genuine Research Center, Egypt | 2014-04-01 |
| Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers (NCT02097472) | PATH | 2014-04-01 |
| Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis (NCT02243787) | Covagen | 2014-04-01 |
| Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma (NCT02229071) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2014-04-01 |
| A Study to Investigate the Phototoxic Potential of Faldaprevir (NCT02114671) | Boehringer Ingelheim | 2014-04-01 |
| A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival (NCT01996826) | Reza Dana, MD | 2014-04-01 |
| Safety Study of Multikine in the Treatment of Perianal Warts (NCT02115919) | United States Naval Medical Center, San Diego | 2014-04-01 |
| Mechanism of tDCS-induced Learning Enhancement - the Role of Serotonin (NCT02092974) | Charite University, Berlin, Germany | 2014-04-01 |
| Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors (NCT02048709) | Genentech, Inc. | 2014-04-01 |
| Dermal Tolerability of Dapsone Gel in Healthy Volunteers (NCT02117752) | Almirall, S.A. | 2014-04-01 |
| Multivirus-specific Cytotoxic T Lymphocytes (mCTL) (NCT02510404) | Catherine Bollard | 2014-04-01 |
| Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (NCT02060253) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma (NCT01811992) | University of Michigan Rogel Cancer Center | 2014-04-01 |
| Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg (NCT02593500) | Reig Jofre Group | 2014-04-01 |
| Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck (NCT02110992) | University of Cincinnati | 2014-04-01 |
| Reduction of C-Difficile Infection Using Stool Transplant (NCT02112279) | Providence Holy Cross Medical Center | 2014-04-01 |
| A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors (NCT02145559) | University of Chicago | 2014-04-01 |
| Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects (NCT02084953) | Bristol-Myers Squibb | 2014-04-01 |
| A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161 (NCT02125162) | BioCryst Pharmaceuticals | 2014-04-01 |
| Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets (NCT02106923) | Boehringer Ingelheim | 2014-04-01 |
| Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta (NCT02172885) | Hospital de Cruces | 2014-04-01 |
| A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662 (NCT02194491) | Astellas Pharma Global Development, Inc. | 2014-04-01 |
| Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations (NCT02209454) | Menarini Group | 2014-04-01 |
| A Study of Cephalexin Capsules in Healthy Participants (NCT02123446) | Eli Lilly and Company | 2014-04-01 |
| Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor (NCT02069158) | Cristiana Sessa | 2014-04-01 |
| Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers (NCT02125227) | Yuhan Corporation | 2014-04-01 |
| Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer (NCT02213497) | Abramson Cancer Center at Penn Medicine | 2014-04-01 |
| Study to Investigate the Pharmacokinetics of CHF 6001 DPI Administered Via Nexthaler® Device or the Capsule for Oral Inhalation Via Aerolizer® Device (NCT02119247) | Chiesi Farmaceutici S.p.A. | 2014-04-01 |
| A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue (NCT02109029) | Eli Lilly and Company | 2014-04-01 |
| Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution (NCT02145507) | Haemonetics Corporation | 2014-04-01 |
| A Study Evaluating the Safety of Escalating Doses of DLYE5953A in Patients With Refractory Solid Tumors (NCT02092792) | Genentech, Inc. | 2014-04-01 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults (NCT02114268) | MedImmune LLC | 2014-04-01 |
| Study of CXA-10 in Healthy Volunteers (NCT02127190) | Complexa, Inc. | 2014-04-01 |
| A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants (NCT02109042) | Eli Lilly and Company | 2014-04-01 |
| Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers (NCT02332044) | Daewoong Pharmaceutical Co. LTD. | 2014-04-01 |
| Effectiveness of Prophylactic Antibiotics Therapy in Laparoscopic Cholecystectomy on Infection Rate (NCT04726046) | Chonbuk National University Hospital | 2014-04-01 |
| Relative Bioavailability of AR10 Compared to Reference Product (NCT02723669) | Arbor Pharmaceuticals, Inc. | 2014-04-01 |
| A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma (NCT02068079) | Duke University | 2014-04-01 |
| Red Cell Transfusion Goals in Patients With Acute Leukemias (NCT02086773) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer (NCT01948843) | Polaris Group | 2014-04-01 |
| Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 (NCT02095860) | Bristol-Myers Squibb | 2014-04-01 |
| Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors (NCT02122770) | Millennium Pharmaceuticals, Inc. | 2014-04-01 |
| Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer (NCT02106871) | The University of Texas Medical Branch, Galveston | 2014-04-01 |
| A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma (NCT02116569) | Janssen Pharmaceutical K.K. | 2014-04-01 |
| Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging (NCT02266966) | Pierre Fabre Medicament | 2014-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers (NCT02106247) | Boehringer Ingelheim | 2014-04-01 |
| A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan (NCT02387138) | Institut du Cancer de Montpellier - Val d'Aurelle | 2014-04-01 |
| Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies (NCT02128945) | University Hospital, Caen | 2014-04-01 |
| Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum (NCT02356913) | Fertin Pharma A/S | 2014-04-01 |
| A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001 (NCT02096341) | EpicentRx, Inc. | 2014-04-01 |
| A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma (NCT01970358) | Patrick Ott, MD, PhD | 2014-04-01 |
| Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer (NCT02198859) | University of Kansas Medical Center | 2014-04-01 |
| Deep Brain Stimulation for Human Morbid Obesity (NCT02232919) | Hospital do Coracao | 2014-04-01 |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors (NCT02076906) | AeRang Kim | 2014-04-01 |
| A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia (NCT02016729) | Kartos Therapeutics, Inc. | 2014-04-01 |
| Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (NCT02071758) | Access to Advanced Health Institute (AAHI) | 2014-04-01 |
| Testing a Promising Treatment for Youth Substance Abuse in a Community Setting (NCT02130479) | Medical University of South Carolina | 2014-04-01 |
| AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study (NCT02063386) | Ardelyx | 2014-04-01 |
| Pharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular Degeneration (NCT02130531) | Kubota Vision Inc. | 2014-04-01 |
| Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women (NCT02100553) | Pfizer | 2014-04-01 |
| A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer (NCT02069041) | Eli Lilly and Company | 2014-04-01 |
| Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule (NCT02161276) | Guizhou Bailing Group Pharmaceutical Co Ltd | 2014-04-01 |
| Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults (NCT02188810) | Folia Biotech Inc. | 2014-04-01 |